Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Category Archives: Muscular Dystrophy Treatment
Advocates seek homes for research dogs and cats – The Salem News
Posted: Published on September 21st, 2019
BOSTON Thousands of cats and dogs used in medical research are eventually euthanized, according to animal advocates who for years have lobbied the scientific community to instead find homes for them. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Advocates seek homes for research dogs and cats – The Salem News
This Biotech Targets Mitochondria to Treat Inherited… – Labiotech.eu
Posted: Published on September 21st, 2019
As we come to the end of the global Mitochondrial Disease Awareness Week, its time to visit Khondrion. This Dutch company is developing drugs to treat rare diseases such as MELAS syndrome by targeting defective mitochondria Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on This Biotech Targets Mitochondria to Treat Inherited… – Labiotech.eu
CureDuchenne Appoints Lianna Orlando, PhD, to the Position of Senior Director of Research – Business Wire
Posted: Published on September 21st, 2019
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--CureDuchenne, the leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, announced today that Lianna Orlando, PhD has joined the team as Senior Director of Research. In this role, Orlando will help identify and evaluate strategic investments aimed at developing treatments for Duchenne muscular dystrophy. We are very excited to have Lianna join our team she has exactly the skill set we need to find and evaluate the most promising Duchenne research from around the world that has the most potential to achieve our goal of improving and extending the lives of those affected by Duchenne muscular dystrophy, said Debra Miller, founder and CEO, CureDuchenne. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on CureDuchenne Appoints Lianna Orlando, PhD, to the Position of Senior Director of Research – Business Wire
Here’s Why PTC Therapeutics Fell as Much as 12.5% Today – Motley Fool
Posted: Published on September 21st, 2019
What happened Shares of PTC Therapeutics (NASDAQ:PTCT) fell more than 12% after the company announced the pricing of a debt offering and a share offering. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Here’s Why PTC Therapeutics Fell as Much as 12.5% Today – Motley Fool
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, ABMD and SRPT – Yahoo Finance
Posted: Published on September 21st, 2019
NEW YORK, NY / ACCESSWIRE / September 20, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, ABMD and SRPT – Yahoo Finance
CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – Yahoo Finance
Posted: Published on September 21st, 2019
NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – Yahoo Finance
Boulder-based Edgewise Therapeutics raises $50M in Series B round – BizWest
Posted: Published on September 21st, 2019
BOULDER Edgewise Therapeutics Inc. closed a $50 million Series B fundraising round for its research into musculoskeletal diseases. According to a press release, Edgewise said the funding will be used to prepare its main drug candidate, a treatment for two forms of muscular dystrophy, for clinical trials. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Boulder-based Edgewise Therapeutics raises $50M in Series B round – BizWest
The wearable cyborgs that use brain waves to power up your muscles – WTOP
Posted: Published on September 21st, 2019
HAL helps those with spinal cord injuries and muscular dystrophy regain their movements and strengthen their nerves and muscles. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on The wearable cyborgs that use brain waves to power up your muscles – WTOP
Jane’s Journey: Genetic condition doesn’t stop this 2-year-old, who is ‘ready, set, go’ – Grand Forks Herald
Posted: Published on September 21st, 2019
Family and friends tried to encourage parents Megan and Bryant Comfort that their baby girl would be alright, but they soon learned that Jane had Spinal Muscular Atrophy. The condition is a genetic disease affecting the part of the nervous system that controls voluntary muscle movement, according to the Muscular Dystrophy Association. What that meant for Jane was that she was essentially paralyzed by the time she was three months old. Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Jane’s Journey: Genetic condition doesn’t stop this 2-year-old, who is ‘ready, set, go’ – Grand Forks Herald
Clinical Catchup: September 16-20 – BioSpace
Posted: Published on September 21st, 2019
Last week was an unusually busy week for clinical trial news, with numerous companies presenting results at conferences. Heres a look at the top stories Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Clinical Catchup: September 16-20 – BioSpace